Featured Research

from universities, journals, and other organizations

New mechanism allowing tumor cells to escape immune surveillance discovered

Date:
March 18, 2014
Source:
Moffitt Cancer Center
Summary:
The immune system plays a pivotal role in targeting cancer cells for destruction. However, tumor cells are smart and have developed ways to avoid immune detection. A collaborative team of researchers recently discovered a novel mechanism that lung cancer cells use to block detection by a type of immune cell called a natural killer cell (NK cell).

The immune system plays a pivotal role in targeting cancer cells for destruction. However, tumor cells are smart and have developed ways to avoid immune detection. A collaborative team of researchers at Moffitt Cancer Center recently discovered a novel mechanism that lung cancer cells use to block detection by a type of immune cell called a natural killer cell (NK cell).

NK cells find and destroy virally infected cells and also play an important role in detecting and killing tumor cells. However, tumors produce high amounts of a protein called Transforming Growth Factor-Beta (TGF-β) that suppresses the activity of NK cells.

A team of researchers led by Julie Y. Djeu, Ph.D., associate center director of education and training at Moffitt, discovered that TGF-β produced by tumor cells causes NK cells to make high levels of a molecule called microRNA-183 (miR-183). MicroRNAs are important regulators of gene expression. They bind to genetic components called RNA and target them for destruction. Scientists discovered in the early 2000s that deregulation of microRNAs can lead to the development of cancer.

Djeu's laboratory reported that miR-183 binds to the RNA for a protein called DAP12, resulting in significantly lower levels of DAP12 in NK cells. DAP12 plays a critical role in activating the NK cells' cytotoxic pathways; therefore, lower levels of DAP12 in NK cells results in a reduced ability to target tumor cells.

The researchers confirmed their observations by studying tissue from lung cancer tumors. They discovered that in normal tissue NK cells had moderate to high levels of DAP12; however, the NK cells within or surrounding the tumor had significantly reduced levels of DAP12.

Djeu explained that, "The world of microRNAs is just being explored, especially within cancer cells, to identify what they control. How microRNAs might intercept immune cells in cancer is unknown and we were able to provide insight into a critical means by which cancer cells exploit miR-183 to dampen immune cell function."

Lung cancer causes the most cancer-related deaths in the United States, and researchers are searching for new cellular targets to increase survival rates. Inhibiting TGF-β is not ideal because it is critical to normal cellular processes. However, the Moffitt scientists suggest that it may be possible to target the TGF-β-miR183-DAP12 pathway in patients with lung cancer to activate the immune system and kill cancer cells.

This study appeared online in Proceedings of the National Academy of Sciences on February 28.


Story Source:

The above story is based on materials provided by Moffitt Cancer Center. Note: Materials may be edited for content and length.


Journal Reference:

  1. S. S. Donatelli, J.-M. Zhou, D. L. Gilvary, E. A. Eksioglu, X. Chen, W. D. Cress, E. B. Haura, M. B. Schabath, D. Coppola, S. Wei, J. Y. Djeu. TGF--inducible microRNA-183 silences tumor-associated natural killer cells. Proceedings of the National Academy of Sciences, 2014; 111 (11): 4203 DOI: 10.1073/pnas.1319269111

Cite This Page:

Moffitt Cancer Center. "New mechanism allowing tumor cells to escape immune surveillance discovered." ScienceDaily. ScienceDaily, 18 March 2014. <www.sciencedaily.com/releases/2014/03/140318111319.htm>.
Moffitt Cancer Center. (2014, March 18). New mechanism allowing tumor cells to escape immune surveillance discovered. ScienceDaily. Retrieved July 30, 2014 from www.sciencedaily.com/releases/2014/03/140318111319.htm
Moffitt Cancer Center. "New mechanism allowing tumor cells to escape immune surveillance discovered." ScienceDaily. www.sciencedaily.com/releases/2014/03/140318111319.htm (accessed July 30, 2014).

Share This




More Health & Medicine News

Wednesday, July 30, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Generics Eat Into Pfizer's Sales

Generics Eat Into Pfizer's Sales

Reuters - Business Video Online (July 29, 2014) Pfizer, the world's largest drug maker, cut full-year revenue forecasts because generics could cut into sales of its anti-arthritis drug, Celebrex. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com
Nigeria Ups Ebola Stakes on 1st Death

Nigeria Ups Ebola Stakes on 1st Death

Reuters - Business Video Online (July 29, 2014) Nigerian authorities have shut and quarantined a Lagos hospital where a Liberian man died of the Ebola virus, the first recorded case of the highly-infectious disease in Africa's most populous economy. David Pollard reports Video provided by Reuters
Powered by NewsLook.com
Running 5 Minutes A Day Might Add Years To Your Life

Running 5 Minutes A Day Might Add Years To Your Life

Newsy (July 29, 2014) According to a new study, just five minutes of running or jogging a day could add years to your life. Video provided by Newsy
Powered by NewsLook.com
Ebola Outbreak Poses Little Threat To U.S.: CDC

Ebola Outbreak Poses Little Threat To U.S.: CDC

Newsy (July 29, 2014) The Ebola outbreak in West Africa poses little threat to Americans, according to officials with the Centers for Disease Control and Prevention. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins